Biotech Presents Another Interesting Opportunity (IBB)

pills-drugs-biotech2
From Contrarian Outlook: Today I want to show you a beaten-down sector that has a long history of crushing the market--and 4 funds that should be on your radar now.
NASDAQ:IBB April 20, 2018 6:39am

The Evolving Outlook On Various Investing Sectors (IYH)

binoculars-look
From BlackRock: As companies evolve, the way we classify them also needs to evolve. Martin Small and Jeff shen talk about how data science can help and why investors should care.
NYSE:IYH April 16, 2018 6:25am

Healthcare ETFs In Focus Amid Blockbuster Cigna-Express Scripts Deal (XLV)

healthcare
From Zacks: Waves of mergers and acquisitions have been heating up the healthcare space this year that could change the landscape of healthcare business. This is especially true given that health insurers are trying to consolidate with pharmacy benefits managers to streamline and cut costs in the drug supply chain.
NYSE:XLV March 12, 2018 6:24am

What’s The Best Biotech ETF To Buy Right Now? (IBB)

pills-drugs-biotech1
From Zacks: The biotech sector has been attracting a lot of investor attention lately. This sector is expected to continue benefiting from increased M&A activities, new drug approvals, better R&D and innovations.
NASDAQ:IBB March 2, 2018 6:03am

Health Care ETFs In Focus As Earnings Season Heats Up (XLV)

healthcare
From Zacks: Healthcare is performing well with the start of the New Year thanks to encouraging industry trends and a favorable policy environment.
NYSE:XLV January 23, 2018 6:17am

Biotech Is Back In A Major Way (IBB)

pills-drugs-biotech2
From Dana Lyons: Left for dead after a bubbly blowoff in 2015, biotech stocks have finally clawed their way back to new highs.
NASDAQ:IBB January 13, 2018 5:04am

Healthcare ETFs In Focus Amid CVS-Aetna Merger (IHF)

cvs-health-logo
From Zacks: The healthcare space is consolidating with the latest development being the potential buyout of Aetna (AET - Free Report) by CVS Health Corp (CVS - Free Report).
NYSE:IHF December 5, 2017 6:01am

Can Biotech ETFs Continue Their Impressive Run In 2018? (IBB)

pills-drugs-biotech3
From Zacks: So far, it's been a good year for biotech stocks with the Nasdaq Biotechnology Index soaring 19.6% year to date.
NASDAQ:IBB November 14, 2017 7:09am

Will Pharmaceutical ETFs Continue To Rally This Holiday Season? (PJP)

pills-drugs-biotech2
From Zacks: As we head toward the end of 2017, the pharma sector continues to perform well, representing a contrast to 2016 when the sector was under immense pressure due to the drug pricing issue.
NYSE:PJP November 8, 2017 6:11am

Outflows Start To Hit The iShares NASDAQ Biotech ETF (IBB)

pills-drugs-biotech2
Analyst/ETF Trader Paul Weisbruch of Street One Financial brings us his daily fund flows update, which today examines a relatively muted ETF landscape that's seen smallish outflows in biotech and some renewed interest in volatility products ahead of earnings season.
NASDAQ:IBB October 24, 2017 11:46am

What’s The Best Health Care ETF? (XLV, VHT)

biotech-medical-pills
From Zacks: The healthcare sector has been in the spotlight lately. President Donald Trump targeted drug companies and accused them of charging extremely high prices (read: ETFs in Focus as IMF ups Global Growth Forecast).
NYSE:VHT October 20, 2017 6:25am

Traders Are Making Bullish Bets On Health Care ETFs (XLV)

healthcare
Healthcare stocks are moving higher today and there is accompanying call buying in November options that are listed on the largest name in the sector in terms of asset size, XLV (SPDR Health Care Select, Expense Ratio 0.14%, $17.5 billion in AUM).
NYSE:XLV October 17, 2017 12:55pm

Big Money Rotating Out Of Health Care As Q4 Begins (XLV)

healthcare
Analyst/ETF Trader Paul Weisbruch of Street One Financial brings us his daily fund flows update, which today points out big demand in ex-U.S. equities, a sector rotation out of some key sector funds, and bullish bets on financials ahead of earnings reports in the space next week.
NYSE:XLV October 4, 2017 11:42am

Biotech Was The Hottest ETF Sector In The Third Quarter (IBB)

pills-drugs-biotech1
From Zacks: The broader market was pretty eventful in the third quarter. While geopolitical and political concerns were rife, those threats couldn't weigh on the equity market returns.
NASDAQ:IBB October 3, 2017 10:09am

Get Free Updates

Join over 50,000 investors who get the latest news from ETFDailyNews.com!

Most Popular


From Our Partners


Explore More from ETFDailyNews.com

Free Daily Newsletter

Get daily ETF insights from our market experts. Never miss another important market development again!

ETFDailyNews.com respects your privacy.

Best ETFs

We've rated and ranked nearly 2,000 ETFs and ETNs using our proprietary SMART Grade system.

View Top Rated ETFs

Best Categories

We've ranked dozens of ETF categories based on relative performance.

Best ETF Categories